miRNAs as biomarkers of therapeutic response to HER2-targeted treatment in breast cancer: A systematic review

miRNAs as biomarkers of therapeutic response to HER2-targeted treatment in breast cancer: A systematic review

Breast cancer is the most common type of lethal cancer in women globally. Women have a 1 in 8 chance of developing breast cancer in their lifetime. Among the four primary molecular subtypes (luminal A, luminal B, HER2+, and triple-negative), HER2+ accounts for 20–25 % of all breast cancer and is rat...

Full description

Bibliographic Details
Main Authors: Thanh Hoa Vo, Esam EL-Sherbieny Abdelaal, Emmet Jordan, Orla O'Donovan, Edel A. McNeela, Jai Prakash Mehta, Sweta Rani
Format: Article
Language:English
Published: Elsevier 2024-03-01
Series:Biochemistry and Biophysics Reports
Subjects:
HER2-Positive breast cancer
miRNAs
Treatment response
HER2 target therapy
Drug resistance
Drug sensitivity
Online Access:http://www.sciencedirect.com/science/article/pii/S2405580823001693

Similar Items

Similar Items